XBIOTECH INC. Income Tax Examination, Penalties and Interest Expense
XBIOTECH INC. (XBIT) reported Income Tax Examination, Penalties and Interest Expense of $0 for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-16.
Discontinued › Expense Statement
us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense · last filed 2020-03-16
- XBIOTECH INC. income tax examination, penalties and interest expense for fiscal 2019 was $0.00.
- XBIOTECH INC. income tax examination, penalties and interest expense for fiscal 2018 was $0.00.
- XBIOTECH INC. income tax examination, penalties and interest expense for fiscal 2017 was $0.00.
- XBIOTECH INC. income tax examination, penalties and interest expense for fiscal 2016 was $0.00.
| Period end | Income Tax Examination, Penalties and Interest Expense 12 month |
|---|---|
| 2019-12-31 | $0.00 10-K · filed 2020-03-16 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-16 |
| 2017-12-31 | $0.00 10-K · filed 2020-03-16 |
| 2016-12-31 | $0.00 10-K/A · filed 2019-03-15 |
| 2015-12-31 | $0.00 10-K · filed 2018-03-16 |
| 2014-12-31 | $0.00 10-K · filed 2017-03-16 |
| 2013-12-31 | $0.00 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |